Are Gaps in Anemia and CKD Equal Across the Board?

Is there a discrepancy in treatment of anemia in racial/ethnic minority patient populations with chronic kidney disease (CKD)?   Credit available for this activity expires: 3/2/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/988794?ecd=bdc_podcast_libsyn_mscpeduhttps://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu

Om Podcasten

​Anemia is a common complication in patients with chronic kidney disease (CKD). In fact, nearly half of all patients with stage 5 CKD have associated anemia. Historically, it has been a challenge to manage anemia in these patients; to successfully treat them clinicians need to understand the pathophysiology of anemia in CKD, why the treatments have been, for the most part, ineffective, and how emerging therapies are overcoming these challenges.